Literature DB >> 16675943

State prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation--United States, 2003.

.   

Abstract

Arthritis is costly (86 billion dollars annually), highly prevalent (affecting 43 million U.S. adults), the leading cause of disability, and associated with substantial disparities in pain, activity limitations, and compromised quality of life. State-based estimates of arthritis prevalence and impact help define the burden of arthritis and provide state arthritis programs with data for program planning. This report summarizes results from the 2003 Behavioral Risk Factor Surveillance System (BRFSS) survey on state-specific prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation in 50 states, the District of Columbia (DC), and three territories. The findings indicated that the prevalence of adults with self-reported doctor-diagnosed arthritis ranged from 17.9% to 37.2% (state median: 27.0%) and with arthritis-attributable activity limitation ranged from 6.3% to 16.7% (state median: 9.9%); the proportion of adults with arthritis-attributable activity limitation among those with self-reported doctor-diagnosed arthritis ranged from 30.1% to 49.8% (state median: 37.4%). These high rates of arthritis prevalence and activity limitation are projected to increase with the aging of the population, requiring increased intervention measures to reduce this impact.

Entities:  

Mesh:

Year:  2006        PMID: 16675943

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  7 in total

1.  Quality of care for gout in the US needs improvement.

Authors:  Jasvinder A Singh; James S Hodges; John P Toscano; Steven M Asch
Journal:  Arthritis Rheum       Date:  2007-06-15

2.  An inverse association between self-reported arthritis and mortality in the elderly: findings from the national long-term care survey.

Authors:  Alexander M Kulminski; Irina V Kulminskaya; Svetlana V Ukraintseva; Kenneth Land; Anatoli I Yashin
Journal:  Rejuvenation Res       Date:  2008-02       Impact factor: 4.663

3.  Medicaid prescription formulary restrictions and arthritis treatment costs.

Authors:  Tricia J Johnson; Stephanie Stahl-Moncada
Journal:  Am J Public Health       Date:  2008-05-29       Impact factor: 9.308

4.  [Chronic musculoskeletal conditions and comorbidities in primary care settings].

Authors:  Catherine Hudon; Martin Fortin; Hassan Soubhi
Journal:  Can Fam Physician       Date:  2008-01       Impact factor: 3.275

5.  "I know I have arthritis but I don't know what type". Understanding and knowledge of this chronic condition.

Authors:  Tiffany K Gill; Catherine L Hill; Robert J Adams; Danny Broderick; Julie Black; Anne W Taylor
Journal:  BMC Musculoskelet Disord       Date:  2010-08-06       Impact factor: 2.362

6.  Health-related quality of life in adults reporting arthritis: analysis from the National Health Measurement Study.

Authors:  Dinesh Khanna; Paul Maranian; Mari Palta; Robert M Kaplan; Ron D Hays; Dasha Cherepanov; Dennis G Fryback
Journal:  Qual Life Res       Date:  2011-02-05       Impact factor: 4.147

7.  Complementary and alternative medicine use in musculoskeletal disorders: does medical skepticism matter?

Authors:  Elizabeth K Wiley-Exley; Thelma J Mielenz; Edward C Norton; Leigh F Callahan
Journal:  Open Rheumatol J       Date:  2007-09-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.